Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Genky Drug Stores CoTSE:9267 +3.24%82 Days Payable is 65.43 as of Mar. 2026, which is 10% above its 10-year median of 59.55. GuruFocus rates TSE:9267 with a GF Score™ of 82/100 and a GF Value™ of 円3,791.60 (Fairly Valued). The stock has 2 warning signs investors should review. Among 610 Healthcare Providers & Services companies, Genky Drug Stores Co ranks better than 54.26% on this metric.
The historical rank and industry rank for Genky Drug Stores Co's Days Payable or its related term are showing as below:
TSE:9267'
s Days Payable Range Over the Past 10 Years
Min: 57.49 Med: 59.55 Max: 62.78
Current: 62.76
During the past 13 years, Genky Drug Stores Co's highest Days Payable was 62.78. The lowest was 57.49. And the median was 59.55.
TSE:9267's Days Payable is ranked better than 54.26% of 610
companies
in the Healthcare Providers & Services industry
Industry Median: 57.21
vs TSE:9267: 62.76
Genky Drug Stores Co's Days Payable
declined
from Mar. 2025 (66.18) to Mar. 2026 (65.43).
It may suggest that Genky Drug Stores Coaccelerated paying its suppliers.
The historical data trend for Genky Drug Stores Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genky Drug Stores Co Days Payable Competitor Comparison
For the Pharmaceutical Retailers subindustry, Genky Drug Stores Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genky Drug Stores Co Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Genky Drug Stores Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Genky Drug Stores Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Genky Drug Stores Co's Days Payable for the fiscal year that ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genky Drug Stores Co (TSE:9267) has a Days Payable of 65.43 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Genky Drug Stores Co and its competitors. This is 10% above median its historical median of 59.55. Over the past decade, Genky Drug Stores Co's Days Payable has ranged from 57.49 to 62.78. According to the industry distribution chart, Genky Drug Stores Co ranks #279 out of 610 companies in the Healthcare Providers & Services industry, placing it in the top 45.7%.
Is Genky Drug Stores Co's Days Payable too high?
Genky Drug Stores Co's current Days Payable of 65.43 is 10% above median its 10-year median of 59.55. Over the past 10 years, this metric has ranged from a low of 57.49 to a high of 62.78. The Healthcare Providers & Services industry median Days Payable is 57.21. Genky Drug Stores Co's value of 65.43 is 14.4% above this industry median. Based on the distribution chart, Genky Drug Stores Co ranks #279 out of 610 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Genky Drug Stores Co has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Genky Drug Stores Co's Days Payable compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Genky Drug Stores Co ranks #279 out of 610 companies for Days Payable. This puts Genky Drug Stores Co in the upper half of its industry. The industry median Days Payable is 57.21. Genky Drug Stores Co's value of 65.43 is 14.4% above this benchmark. Historically, Genky Drug Stores Co's own Days Payable has ranged from 57.49 to 62.78 over the past decade. While the company's 10-year median is 59.55 vs. the industry median of 57.21, Genky Drug Stores Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.21, based on 610 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Genky Drug Stores Co's current Days Payable of 65.43 is 14.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Genky Drug Stores Co and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genky Drug Stores Co's current Days Payable is 65.43, which is 10% above median its own 10-year median of 59.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genky Drug Stores Co stock overvalued right now?
Based on GuruFocus' analysis, Genky Drug Stores Co (TSE:9267) is currently considered Fairly Valued. The stock's GF Value™ is 円3,791.60, compared to a current price of 円3,665.00 — trading 3.3% below its estimated fair value. The current Days Payable is 65.43, which is 10% above median its 10-year median of 59.55 and 14.4% above the Healthcare Providers & Services industry median of 57.21. Genky Drug Stores Co's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Genky Drug Stores Co (TSE:9267), the current Days Payable is 65.43 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Genky Drug Stores Co (TSE:9267) Overvalued in 2026?
Based on GuruFocus' analysis, Genky Drug Stores Co stock appears to be undervalued.
The current stock price of 円3,665.00 is trading 3.3% below its estimated GF Value™ of 円3,791.60.
GuruFocus considers Genky Drug Stores Co to be Fairly Valued.
Key valuation signals for TSE:9267:
Days Payable: 65.43 (10% above median its 10-year median of 59.55)
GF Value™: 円3,791.60 vs. price of 円3,665.00 (3.3% below fair value)
Industry Position: 14.4% above the Healthcare Providers & Services median (#279 of 610)
No single metric tells the full story. See the TSE:9267 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9267 has been successfully added to your 
